In a medicalized retirement home in southwestern France, an 83-year-old Alzheimer's patient, Mme R., engages in a conversation with her artificial intelligence-powered companion, Livana. The AI, designed to mimic the voice of her grandson, Bastien, chats with Mme R. for several minutes, helping to calm her and alleviate symptoms of her condition. Livana's creator, Nicolas Raulin, explains that the AI is 100% personalized, preconfigured by the family and the patient's psychologue to stimulate conversation.
The Livana AI has been tested in a protected unit for Alzheimer's patients at the Septfontoise establishment in Tarn-et-Garonne. According to the French Alzheimer's association, approximately 1.4 million people in France suffer from the neurodegenerative disease, which severely impacts memory, cognitive functions, and autonomy. At Septfontoise, seven out of 29 Alzheimer's patients participate in the Livana experiment, which aims to calm patients during agitation phases without medication.
The use of AI in Alzheimer's care is also being explored at the Broca Living Lab, a research laboratory at the Assistance publique-Hôpitaux de Paris. Dr. Maribel Pino leads the research, which involves robots equipped with AI to interact with elderly patients with cognitive disabilities or loss of autonomy. The laboratory tests various robots, including Miroki, a humanoid robot, and Paro, a therapeutic baby seal.
During a session at the Broca Living Lab, two residents, Michèle and Ginette, interact with the robots. Michèle, 72, engages in a conversation with Miroki, which stimulates her memory and cognitive functions. In contrast, 99-year-old Ginette is hesitant to interact with Miroki but warms up to Paro, which adapts its movements and vocalizations to her behavior.
According to Léa Vecchioni, a psychologist and research engineer at the Broca Living Lab, the robots serve different purposes. Miroki is designed for cognitive stimulation, while Paro aims to calm patients and encourage conversation. The researchers emphasize that the robots are not meant to replace human interaction but rather complement the care provided by healthcare professionals.
The use of AI and robots in healthcare raises questions about the potential for future applications. Dr. Pino notes that with the shortage of caregivers in the aging population, there is a growing interest in social robotics and assistance. However, she stresses the importance of defining the roles and limitations of robots in healthcare to ensure they are used effectively and safely.
As the use of AI in Alzheimer's care continues to evolve, researchers and healthcare professionals are working together to develop innovative solutions that prioritize patient well-being and safety. The goal is to harness the potential of AI to improve the lives of Alzheimer's patients and support their caregivers, while ensuring that human interaction remains a vital component of care.
Key points
- France is at the forefront of using AI to support Alzheimer's patients, with initiatives such as Livana and the Broca Living Lab's research on robots and AI-powered companions.
- The use of AI in Alzheimer's care aims to calm patients, stimulate cognitive functions, and support caregivers, but researchers emphasize that human interaction remains essential.
- The development of AI in healthcare raises questions about future applications, highlighting the need for careful consideration of the roles and limitations of robots in healthcare.
